Literature DB >> 33656752

Outcomes in adolescent and young adult acute lymphoblastic leukaemia: a report from the Indian Acute Leukaemia Research Database (INwARD) of the Hematology Cancer Consortium (HCC).

Prasanth Ganesan1, Hasmukh Jain2, Bhausaheb Bagal2, Papagudi G Subramanian3, Biju George4, Anu Korula4, Nikita Mehra5, Jayachandran P Kalaiyarasi5, Dinesh Bhurani6, Narendra Agrawal6, Rayaz Ahmed6, Smita Kayal1, Jina Bhattacharyya7, Uday Yanamandra8, Suman Kumar8, Chepsy C Philip9, M Joseph John9, Ambily Nadaraj10, Omprakash Karunamurthy10, Jeyaseelan Lakshmanan10, Vikram Mathews4, Manju Sengar2.   

Abstract

Entities:  

Keywords:  India; acute lymphoblastic leukaemia; adolescent and young adult; outcomes; survival; treatment abandonment

Year:  2021        PMID： 33656752      PMCID： PMC7610916          DOI： 10.1111/bjh.17268

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  13 in total

Review 1.  Acute lymphoblastic leukemia in adolescents and young adults.

Authors:  Michael E Rytting; Elias J Jabbour; Susan M O'Brien; Hagop M Kantarjian
Journal:  Cancer       Date:  2017-03-22       Impact factor: 6.860

2.  Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen.

Authors:  Michael E Rytting; Elias J Jabbour; Jeffrey L Jorgensen; Farhad Ravandi; Anna R Franklin; Tapan M Kadia; Naveen Pemmaraju; Naval G Daver; Alessandra Ferrajoli; Guillermo Garcia-Manero; Marina Y Konopleva; Gautam Borthakur; Rebecca Garris; Sa Wang; Sherry Pierce; Kurt Schroeder; Steven M Kornblau; Deborah A Thomas; Jorge E Cortes; Susan M O'Brien; Hagop M Kantarjian
Journal:  Am J Hematol       Date:  2016-06-30       Impact factor: 10.047

3.  Efficacy and toxicity of a paediatric protocol in teenagers and young adults with Philadelphia chromosome negative acute lymphoblastic leukaemia: results from UKALL 2003.

Authors:  Rachael Hough; Clare Rowntree; Nick Goulden; Chris Mitchell; Anthony Moorman; Rachel Wade; Ajay Vora
Journal:  Br J Haematol       Date:  2015-12-18       Impact factor: 6.998

4.  Acute Lymphoblastic Leukemia in Young Adults Treated with Intensive "Pediatric" Type Protocol.

Authors:  Prasanth Ganesan; Tenali Gnana Sagar; Krishnarathinam Kannan; Venkatraman Radhakrishnan; Manikandan Dhanushkodi; Rajaraman Swaminathan; Shirley Sundersingh; Trivadi S Ganesan
Journal:  Indian J Hematol Blood Transfus       Date:  2017-10-17       Impact factor: 0.900

5.  A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403.

Authors:  Wendy Stock; Selina M Luger; Anjali S Advani; Jun Yin; Richard C Harvey; Charles G Mullighan; Cheryl L Willman; Noreen Fulton; Kristina M Laumann; Greg Malnassy; Elisabeth Paietta; Edy Parker; Susan Geyer; Krzysztof Mrózek; Clara D Bloomfield; Ben Sanford; Guido Marcucci; Michaela Liedtke; David F Claxton; Matthew C Foster; Jeffrey A Bogart; John C Grecula; Frederick R Appelbaum; Harry Erba; Mark R Litzow; Martin S Tallman; Richard M Stone; Richard A Larson
Journal:  Blood       Date:  2019-01-18       Impact factor: 25.476

6.  Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group.

Authors:  F Hayakawa; T Sakura; T Yujiri; E Kondo; K Fujimaki; O Sasaki; J Miyatake; H Handa; Y Ueda; Y Aoyama; S Takada; Y Tanaka; N Usui; S Miyawaki; S Suenobu; K Horibe; H Kiyoi; K Ohnishi; Y Miyazaki; S Ohtake; Y Kobayashi; K Matsuo; T Naoe
Journal:  Blood Cancer J       Date:  2014-10-17       Impact factor: 11.037

7.  Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial.

Authors:  B Patel; A A Kirkwood; A Dey; D I Marks; A K McMillan; T F Menne; L Micklewright; P Patrick; S Purnell; C J Rowntree; P Smith; A K Fielding
Journal:  Leukemia       Date:  2016-08-02       Impact factor: 11.528

8.  The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study.

Authors:  Sumit Gupta; Jason D Pole; Nancy N Baxter; Rinku Sutradhar; Cindy Lau; Chenthila Nagamuthu; Paul C Nathan
Journal:  Cancer Med       Date:  2019-03-26       Impact factor: 4.452

9.  Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia.

Authors:  D J DeAngelo; K E Stevenson; S E Dahlberg; L B Silverman; S Couban; J G Supko; P C Amrein; K K Ballen; M D Seftel; A R Turner; B Leber; K Howson-Jan; K Kelly; S Cohen; J H Matthews; L Savoie; M Wadleigh; L A Sirulnik; I Galinsky; D S Neuberg; S E Sallan; R M Stone
Journal:  Leukemia       Date:  2014-07-31       Impact factor: 11.528

10.  Adult Acute Lymphoblastic Leukemia: Limitations of Intensification of Therapy in a Developing Country.

Authors:  Punit Jain; Anu Korula; Prashant Deshpande; Nisham Pn; Ansu Abu Alex; Aby Abraham; Alok Srivastava; Nancy Beryl Janet; Kavitha M Lakshmi; Poonkuzhali Balasubramanian; Biju George; Vikram Mathews
Journal:  J Glob Oncol       Date:  2018-09
View more
  2 in total

1.  Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocol.

Authors:  Akhil Rajendra; Hasmukh Jain; V N Avinash Bonda; Lingaraj Nayak; Prashant Tembhare; Dhanlaxmi Shetty; Jayashree Thorat; Hemani Jain; Papagudi Ganesan Subramanian; Nikhil Patkar; Gaurav Chatterjee; Navin Khattry; Anant Gokarn; Sachin Punatar; Smruti Mokal; Bhausaheb Bagal; Manju Sengar
Journal:  Blood Adv       Date:  2021-03-09

Review 2.  Precursor B-cell acute lymphoblastic leukaemia-a global view.

Authors:  Andrea Biondi; Valentino Conter; Mammen Chandy; Primus Ewald; Marie Lucia de Martino Lee; Vivek S Radhakrishnan; Wannaphorn Rotchanapanya; Patricia Scanlan; Owen Patrick Smith; Boubacar Togo; Peter Hokland
Journal:  Br J Haematol       Date:  2021-12-20       Impact factor: 8.615
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.